Stay updated on Pembrolizumab in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Metastatic NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab in Metastatic NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a new version of the page documentation. This update changes only the version tag and does not modify the study details shown on the page.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe Study Protocol and Statistical Analysis Plan document revision was updated from v3.6.3 to v3.6.4, indicating a newer version is now available.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page’s revision label was updated from v3.6.2 to v3.6.3, indicating a small update to the document or template rather than a change to trial information.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page's revision tag was updated to v3.6.2, replacing the previous v3.6.0 and indicating a refreshed page version.SummaryDifference0.1%

- Check66 days agoChange DetectedRecruitment status on the study page was updated to indicate that no more participants are being sought. At the same time, the page adds new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and logs a new Revision: v3.6.0, while older labels such as Intervention / Treatment and Revision: v3.5.5 were removed.SummaryDifference0.5%

- Check73 days agoChange DetectedThe page shows a revision update from v3.5.4 to v3.5.5, indicating a minor backend or UI update without changing the study details.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Metastatic NSCLC Clinical Trial page.